|
Replication-deficient
vectors
SFV
SIN
VEE
|
Liljeström and Garoff, 1991
Xiong et al., 1989
Davis et al., 1989
|
|
Non-cytopathogenic
vectors
SFV
SIN
|
Lundstrom et al., 1999b
Agapov et al., 1998
|
|
Replication
persistent vectors
SFV and SIN
|
Perri et al., 2000
|
|
Temperature-sensitive
vectors
SFV
SIN
|
Lundstrom et al., 2001
Boorsma et al., 2000
|
|
Targeted vectors
SIN
|
Ohno et al., 1997
|
|
Layered DNA vectors
SFV
SIN
|
Berglund et al., 1996
Dubensky et al., 1996
|
|
Tumor vaccines
Naked RNA
DNA / particles
|
Ying et al., 1999
Colmenero et al., 1999
|
|
Production of
retrovirus particles
SFV
|
Li and Garoff, 1996
Wahlfors et al, 1997
|
|
In vivo gene
delivery
SFV
SIN
|
Lundstrom et al., 1999a
Altman-Hamandzic et al.,
1997
|
|
Tumor cell lines
SFV
|
Hardy et al., 2000
|
|
Tumor models
SFV – mouse /
B16 melanoma
SFV – mouse / human lung carcinoma
|
Asselin-Paturel et al.,
1999
Murphy et al., 2000
|
|
Packaging cell line
SIN and SFV
|
Polo et al., 1999
|
|
Split two-helper
system
SFV
|
Smerdou and Liljeström, 1999
|